Product containing precisely tapentadol 250 milligram/1 each modified-release oral tablet 1 tablet tablet (clinical drug)
| Code | 18672111000001109 |
|---|---|
| Semantic tag | clinical drug |
| Module | uk-clinical |
| Definition | defined |
| Effective time | 20250924 |
777675005Tapentadol
medicinal product
10363801000001108Virtual medicinal product
product
39585911000001102Ationdo SR 250mg tablets (Grunenthal Ltd)
real clinical drug
43000611000001103Lupaxis 250mg prolonged-release tablets (Dr Reddy's Laboratories (UK) Ltd)
real clinical drug
18665211000001104Palexia SR 250mg tablets (Grunenthal Ltd)
real clinical drug
42675511000001100Tadomon 250mg prolonged-release tablets (G.L. Pharma UK Ltd)
real clinical drug
42899511000001103Tapentadol 250mg modified-release tablets (A A H Pharmaceuticals Ltd)
real clinical drug
42897711000001100Tapentadol 250mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
real clinical drug
42998911000001106Tapentadol 250mg modified-release tablets (Aspire Pharma Ltd)
real clinical drug
43143011000001102Tapentadol 250mg modified-release tablets (Medical Valley Invest AB)
real clinical drug
42771111000001104Tapentadol 250mg modified-release tablets (Viatris UK Healthcare Ltd)
real clinical drug
43216011000001101Vecicom 250mg prolonged-release tablets (Celix Pharma Ltd)
real clinical drug